396 related articles for article (PubMed ID: 30327561)
21. Insight into partial agonism by observing multiple equilibria for ligand-bound and G
Solt AS; Bostock MJ; Shrestha B; Kumar P; Warne T; Tate CG; Nietlispach D
Nat Commun; 2017 Nov; 8(1):1795. PubMed ID: 29176642
[TBL] [Abstract][Full Text] [Related]
22. Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol.
Isogaya M; Yamagiwa Y; Fujita S; Sugimoto Y; Nagao T; Kurose H
Mol Pharmacol; 1998 Oct; 54(4):616-22. PubMed ID: 9765503
[TBL] [Abstract][Full Text] [Related]
23. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization.
Moore RH; Millman EE; Godines V; Hanania NA; Tran TM; Peng H; Dickey BF; Knoll BJ; Clark RB
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):254-61. PubMed ID: 16980556
[TBL] [Abstract][Full Text] [Related]
24. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
[TBL] [Abstract][Full Text] [Related]
25. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
Singh M; Moniri NH
Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
[TBL] [Abstract][Full Text] [Related]
26. Identification of a β-arrestin-biased negative allosteric modulator for the β
Ippolito M; De Pascali F; Hopfinger N; Komolov KE; Laurinavichyute D; Reddy PAN; Sakkal LA; Rajkowski KZ; Nayak AP; Lee J; Lee J; Cao G; Donover PS; Reichman M; An SS; Salvino JM; Penn RB; Armen RS; Scott CP; Benovic JL
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2302668120. PubMed ID: 37490535
[TBL] [Abstract][Full Text] [Related]
27. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L
J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174
[TBL] [Abstract][Full Text] [Related]
28. β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients.
Mochizuki H; Nanjo Y; Kawate E; Yamazaki M; Tsuda Y; Takahashi H
Lung; 2012 Aug; 190(4):411-7. PubMed ID: 22526864
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of β
Susec M; Sencanski M; Glisic S; Veljkovic N; Pedersen C; Drinovec L; Stojan J; Nøhr J; Vrecl M
Neuropharmacology; 2019 Jul; 152():78-89. PubMed ID: 30707913
[TBL] [Abstract][Full Text] [Related]
30. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.
Weiss DR; Ahn S; Sassano MF; Kleist A; Zhu X; Strachan R; Roth BL; Lefkowitz RJ; Shoichet BK
ACS Chem Biol; 2013 May; 8(5):1018-26. PubMed ID: 23485065
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of an atypical Gαs-biased β
Kim D; Tokmakova A; Lujan LK; Strzelinski HR; Kim N; Najari Beidokhti M; Giulianotti MA; Mafi A; Woo JA; An SS; Goddard WA; Liggett SB
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34857633
[TBL] [Abstract][Full Text] [Related]
32. Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.
Liu JJ; Horst R; Katritch V; Stevens RC; Wüthrich K
Science; 2012 Mar; 335(6072):1106-10. PubMed ID: 22267580
[TBL] [Abstract][Full Text] [Related]
33. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
34. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
35. Small-Molecule Positive Allosteric Modulators of the
Ahn S; Pani B; Kahsai AW; Olsen EK; Husemoen G; Vestergaard M; Jin L; Zhao S; Wingler LM; Rambarat PK; Simhal RK; Xu TT; Sun LD; Shim PJ; Staus DP; Huang LY; Franch T; Chen X; Lefkowitz RJ
Mol Pharmacol; 2018 Aug; 94(2):850-861. PubMed ID: 29769246
[TBL] [Abstract][Full Text] [Related]
36. In silico identification of a β
Shah SD; Lind C; De Pascali F; Penn RB; MacKerell AD; Deshpande DA
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2214024119. PubMed ID: 36449547
[TBL] [Abstract][Full Text] [Related]
37. Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.
Littmann T; Göttle M; Reinartz MT; Kälble S; Wainer IW; Ozawa T; Seifert R
J Pharmacol Exp Ther; 2015 Nov; 355(2):183-90. PubMed ID: 26306764
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of intracellular allosteric β
Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
[TBL] [Abstract][Full Text] [Related]
39. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
40. Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
Rosenbaum DM; Zhang C; Lyons JA; Holl R; Aragao D; Arlow DH; Rasmussen SG; Choi HJ; Devree BT; Sunahara RK; Chae PS; Gellman SH; Dror RO; Shaw DE; Weis WI; Caffrey M; Gmeiner P; Kobilka BK
Nature; 2011 Jan; 469(7329):236-40. PubMed ID: 21228876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
